Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen
Status:
Terminated
Trial end date:
2019-06-15
Target enrollment:
Participant gender:
Summary
This study is a randomized, placebo-controlled study of desvenlafaxine versus placebo. The
purpose of this study is to determine if desvenlafaxine was effective in decreasing the
frequency and severity of hot flashes in breast cancer patients taking tamoxifen.
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Collaborators:
Korea Cancer Center Hospital Pfizer Seoul National University Bundang Hospital